文献速递胸部CT

总肿瘤大小对表现为部分实性结节的临床IA期肺腺癌患者预后的影响:仅有实性部分大小重要吗?

Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
PubMed 文献 · Eur Radiol · 2018-08-21

该回顾性单中心研究纳入506例临床IA期表现为部分实性结节、行标准肺叶切除术的肺腺癌患者,分析总肿瘤大小、实性部分大小及临床T分期的预后价值。多因素Cox回归显示总肿瘤大小与cT1b的交互项及cT1c是复发的独立危险因素;cT1b中总肿瘤大小>3.0 cm者复发风险显著更差(HR=3.796),与cT1c无显著差异(p=0.915)。结论认为cT1b中总肿瘤大小>3.0 cm者应考虑升级分期。

要点

  • cT1b中总肿瘤大小>3.0 cm者复发风险显著高于≤3.0 cm者(HR=3.796),与cT1c无显著差异(p=0.915)。
  • 总肿瘤大小与cT1b的交互项(HR=1.091,p=0.019)及cT1c(HR=68.436,p=0.010)为复发独立危险因素。
  • 当前T描述符在表现为部分实性结节的IA期腺癌中是强有力的预后因素。

核心结论

  • 总肿瘤大小是cT1b无淋巴结或远处转移腺癌患者的显著预后因素,cT1b中总肿瘤大小>3.0 cm者的肺癌复发风险与cT1c相当。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准,纳入506例(男:女=200:306;中位年龄62岁)临床IA期腺癌谱部分实性结节患者,均在单一三级医疗中心接受标准肺叶切除术。

诊断标准与关键数值

  • 多因素Cox回归显示总肿瘤大小与cT1b的交互项为复发的独立危险因素(HR=1.091;95%CI:1.015,1.173;p=0.019)。
  • cT1c为复发的独立危险因素(HR=68.436;95%CI:2.797,1674.415;p=0.010)。
  • cT1b患者以总肿瘤大小3.0 cm为界二分,总肿瘤大小>3.0 cm者预后显著更差(HR=3.796;95%CI:1.006,14.317;p=0.049)。
  • cT1b且总肿瘤大小>3.0 cm与cT1c的复发概率无显著差异(p=0.915)。

临床应用与阅片要点

  • 作者认为,cT1b且总肿瘤大小>3.0 cm的肿瘤升级分期可能更合适。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim was to investigate the effect of clinico-radiologic variables, including total tumor (Ttotal) size and clinical T category, on the prognosis of patients with stage IA (T1N0M0) lung adenocarcinomas appearing as part-solid nodules (PSNs).

METHODS: This institutional review board-approved retrospective study included 506 patients (male:female = 200:306; median age, 62 years) with PSNs of the adenocarcinoma spectrum in clinical stage IA who underwent standard lobectomy at a single tertiary medical center. Prognostic stratification of the patients in terms of disease-free survival was analyzed with variables including age, sex, Ttotal size, solid portion size, clinical T category, and tumor location using univariate and subsequent multivariate Cox regression analysis. Subgroup analysis was performed to reveal the effect of the Ttotal size at each clinical T category.

RESULTS: Multivariate Cox regression analysis demonstrated that Ttotal size*cT1b [interaction term; hazard ratio (HR) = 1.091; 95% confidence interval (CI): 1.015, 1.173; p = 0.019] and cT1c (HR = 68.436; 95% CI: 2.797, 1674.415; p = 0.010) were independent risk factors for the tumor recurrence. When patients with cT1b were dichotomized based on a Ttotal size cutoff of 3.0 cm, PSNs with Ttotal > 3.0 cm showed a significantly worse outcome (HR = 3.796; 95% CI: 1.006, 14.317; p = 0.049). No significant difference was observed in the probability of recurrence between cT1b with Ttotal > 3.0 cm and cT1c (p = 0.915).

CONCLUSIONS: Ttotal size is a significant prognostic factor in adenocarcinoma patients in cT1b without lymph node or distant metastasis. PSNs in cT1b with Ttotal > 3.0 cm have a comparable risk of lung cancer recurrence to those in cT1c.

KEY POINTS: • Current T descriptor was a powerful prognostic factor in stage IA adenocarcinomas appearing as part-solid nodules. • Total tumor size further stratified risk of recurrence of adenocarcinomas in cT1b. • Upstaging of tumors in cT1b with total tumor size > 3.0 cm may be more appropriate.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kim H, Goo JM, Suh YJ, et al. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter? Eur Radiol. 2018. PMID: 30132107. doi:10.1007/s00330-018-5685-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。